Postdoctoral Training for Translating Research in Regenerative Medicine

再生医学研究转化博士后培训

基本信息

  • 批准号:
    10263913
  • 负责人:
  • 金额:
    $ 17.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-01 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The current NIBIB T32 postdoctoral training program, "Training Without Borders: Translational Research in Regenerative Medicine" (2012-2017), has focused on two innovative features: (1) the concept of a geographically dispersed training faculty to harness a unique team of mentors; and (2) a combination of conventional academic training (state-of-the-art science, proposal writing, responsible conduct of research) together with training in translation and commercialization. This has resulted in a geographically dispersed "community of learning". The core strength of this program has been its interdisciplinary breadth, providing trainees with opportunities to conduct research on rationally designed biomaterials, bioactive microenvironments, cell profiling technologies, and regenerative biology. Based on this success the proposed training program (2018-2023) will retain the current structure, revise the mentor-institution network, and use a new paradigm - Bench-to-Business-to-Bedside (B3). While the term Bench-to-Bedside is often used to describe translation, we believe that the B3 model offers more relevant training in translation by providing trainees with mentoring constellations consisting of academic, industrial, and clinical subject matter experts. In addition to focusing on state-of-the-art science, postdoctoral training programs must improve the chances of their trainees finding employment across all sectors: academia, industry, and alternative career paths, in order to ultimately achieve clinical therapies. We have coined the term "innovation-primed science" to represent a range of breakthrough, innovation- generating scientific ideas that will offer our trainees a range of scientific projects to work on, from pioneering basic science to commercialization-ready projects, for which proof-of-concept has already been established. We will create a unique training infrastructure that is made up not only of the traditional academic mentors (scientific or clinical faculty who lead top laboratories), but also of a Translation Advisory Board (TAB) comprising experts in regenerative medicine and clinical practice, entrepreneurs, industrial scientists, investors, and leading subject-matter experts in translation and commercialization. The TAB will effectively fill the expertise gap among our academic faculty mentors, by completing a mentoring constellation of academic, industrial, and clinical experts for each trainee. A rich didactic program will combine both established approaches and new concepts to deliver a balance of experience to trainees while optimizing the expertise of 14 core mentors and 16 clinical, industrial and entrepreneurial advisors. Specific program elements are Individualized B3 Mentoring Constellations, Face-to- Face Interactions and Workshops, Online Interactions and Seminar Series, Defined and Monitored Integration of Didactic Elements during the Fellowship Term, Mentoring of Trainees and Professional Development, and Supporting Junior Mentors.
项目摘要/摘要 当前的Nibib T32博士后培训计划:“无国界的培训:转化研究 再生医学”(2012-2017),重点介绍了两个创新特征:(1) 地理分散的培训教师,以利用独特的导师团队; (2)组合 常规学术培训(最先进的科学,提案写作,负责任的研究行为) 以及翻译和商业化的培训。这导致了地理上分散的 “学习社区”。该计划的核心优势是其跨学科的广度,提供 学员有机会对合理设计的生物材料,生物活性进行研究 微环境,细胞分析技术和再生生物学。 基于这一成功,拟议的培训计划(2018-2023)将保留当前的结构,修改 指导机构网络,并使用新的范式 - 替补阶层(B3)。而术语 台式卧式通常用于描述翻译,我们认为B3模型提供了更相关的 通过为学员提供由学术,工业和 临床主题专家。除了专注于最先进的科学,博士后培训 计划必须提高学员的机会,从而在所有领域找到就业:学术界, 行业和替代职业道路,以最终实现临床疗法。 我们创造了“创新的科学”一词,以代表一系列突破性,创新 - 产生科学思想,将为我们的学员提供一系列科学项目,从开创性 已经建立了有关商业化项目的基础科学,已建立了概念验证。 我们将创建一个独特的培训基础设施,不仅由传统的学术导师组成 (领导顶级实验室的科学或临床教师),但也是翻译咨询委员会(TAB) 包括再生医学和临床实践专家,企业家,工业科学家, 投资者以及领先的翻译和商业化专家。标签将有效地填充 我们的学术教师导师之间的专业知识差距是通过完成学术的指导星座的 每个学员的工业和临床专家。 丰富的教学计划将结合既定方法和新概念,以实现平衡 在优化14位核心导师和16位临床,工业和 企业家顾问。特定的程序要素是个性化的B3指导星座,面对面 面对互动和讲习班,在线互动和研讨会系列,定义和监视集成 奖学金期间的教学要素,指导学员和专业发展以及 支持初级导师。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Kibum Lee的其他基金

Investigating mitochondrial dysfunction in neurodegeneration using A Nanoparticle-based Synthetic Mitochondrial DNA (mtDNA) Transcription Regulator
使用基于纳米颗粒的合成线粒体 DNA (mtDNA) 转录调节器研究神经退行性变中的线粒体功能障碍
  • 批准号:
    10679826
    10679826
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Injectable Hybrid SMART spheroids to enhance stem cell therapy for CNS injuries
可注射混合 SMART 球体增强干细胞治疗中枢神经系统损伤
  • 批准号:
    10752890
    10752890
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Nanoparticle-based synthetic transcription factor to induce stem cell myogenesis
基于纳米颗粒的合成转录因子诱导干细胞肌发生
  • 批准号:
    9461879
    9461879
  • 财政年份:
    2017
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Novel magnetic core/shell nanoparticle-based stem cell therapy to direct neural s
新型磁核/壳纳米颗粒干细胞疗法可指导神经系统
  • 批准号:
    8623454
    8623454
  • 财政年份:
    2013
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Novel magnetic core/shell nanoparticle-based stem cell therapy to direct neural s
新型磁核/壳纳米颗粒干细胞疗法可指导神经系统
  • 批准号:
    8737987
    8737987
  • 财政年份:
    2013
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Combinatorial approaches for studying multiple cues regulating human pluripotent
研究调节人类多能性的多种线索的组合方法
  • 批准号:
    7848757
    7848757
  • 财政年份:
    2009
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Postdoctoral Training for Translating Research in Regenerative Medicine
再生医学研究转化博士后培训
  • 批准号:
    10430245
    10430245
  • 财政年份:
    2000
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:

相似国自然基金

翻译起始因子EIF3H在前列腺癌发生发展中的作用及机制研究
  • 批准号:
    82372628
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高效低资源机器翻译模型设计及预训练方法研究
  • 批准号:
    62306284
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
mRNA疫苗与药物在翻译蛋白中的糖基化研究
  • 批准号:
    22377049
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
胆固醇代谢调控线粒体去酰化酶Sirt5介导的蛋白翻译后修饰在骨关节炎中的作用与机制研究
  • 批准号:
    82302746
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
m6A识别蛋白YTHDF1促进LAMP2A翻译调控肺泡上皮细胞铁死亡在肺缺血再灌注损伤中的作用及机制研究
  • 批准号:
    82300125
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Next generation massively multiplexed combinatorial genetic screens
下一代大规模多重组合遗传筛选
  • 批准号:
    10587354
    10587354
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Interpreting Bone Morphogenetic Protein Gradients in Vertebrate Development
解释脊椎动物发育中的骨形态发生蛋白梯度
  • 批准号:
    10677094
    10677094
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Pivotal Preclinical Studies of Novel Infusible ECM for Treating Acute MI
新型不输 ECM 治疗急性 MI 的关键临床前研究
  • 批准号:
    10699610
    10699610
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
  • 批准号:
    10556192
    10556192
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10630392
    10630392
  • 财政年份:
    2023
  • 资助金额:
    $ 17.79万
    $ 17.79万
  • 项目类别: